CareTrust REIT (CTRE) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 May, 2026Executive summary
Q1 2026 delivered net income attributable to shareholders of $80.2 million ($0.36 per diluted share), up from $65.8 million in Q1 2025, with total revenues rising 48% to $142.8 million.
Normalized FFO reached $107.4 million ($0.48/share), up 14% year-over-year, and normalized FAD was $107.6 million ($0.48/share), up 12%.
Q1 2026 saw $245 million in investments closed at an 8.8% blended stabilized yield, with momentum accelerating into Q2 and a $1.1 billion year-to-date total.
Portfolio expanded to 588 properties and 54,415 beds/units, with significant growth in skilled nursing, senior housing, and U.K. care homes.
Dividend increased 16.4% to $0.39 per share, and Moody's upgraded the credit rating to investment grade.
Financial highlights
Normalized FFO per share was $0.48 (up 14%) and normalized FAD per share was $0.48 (up 12%) compared to Q1 2025.
Total revenues for Q1 2026 were $142.8 million, up from $96.6 million in Q1 2025.
Net income attributable to shareholders was $80.2 million, up from $65.8 million a year ago.
100% of contractual rent and interest collected in Q1.
Operating cash flow increased to $90.4 million from $71.4 million year-over-year.
Outlook and guidance
2026 full-year normalized FFO per share guidance raised to $2.00–$2.04, and FAD per share to $1.98–$2.02, with net income guidance of $1.49–$1.53 per share.
Midpoints represent 14.8% and 13.6% increases over 2025, and 4.9% and 3.9% above initial 2026 guidance.
Guidance assumes no new investments, loans, or dispositions beyond those completed year-to-date, 2.5% rent escalators, and $145 million in loan repayments.
Management expects continued growth through acquisitions and loan originations, supported by strong liquidity and access to capital.
CMS updates for 2026 and proposed 2027 rules expected to partially offset higher tenant costs.
Latest events from CareTrust REIT
- Record capital deployment and performance-driven executive pay defined 2025.CTRE
Proxy filing24 Mar 2026 - Proxy seeks approval for director elections, executive pay, and auditor ratification after a record growth year.CTRE
Proxy Filing13 Mar 2026 - Definitive proxy statement outlines annual meeting proposals and confirms board oversight.CTRE
Proxy Filing13 Mar 2026 - Record 2025 growth and robust 2026 outlook with strong FFO, FAD, and pipeline momentum.CTRE
Q4 20254 Mar 2026 - Double-digit FFO growth, robust investments, and industry-leading returns drive shareholder value.CTRE
Investor presentation2 Mar 2026 - Q2 2024 saw record investments, robust growth, and historic low leverage with strong liquidity.CTRE
Q2 20242 Feb 2026 - Q3 2024 net income hit $33.4M, with record investments and a robust pipeline.CTRE
Q3 202417 Jan 2026 - $817M acquisition of 137 U.K. care homes brings accretion, diversification, and growth.CTRE
M&A Announcement25 Dec 2025 - Q1 2025 saw record earnings, a dividend hike, and a major UK acquisition set to close.CTRE
Q1 202523 Dec 2025